Mutations in protein coding-sequence and regulatory elements can cause altered gene expression which can cause diseases. Mis-regulated gene expression can be corrected by direct editing of genomic elements. Indeed, artificial transcription factors can regulate gene expression resulting rescue phenotypes. The fact that less than 2% of our genome encodes protein suggests regulatory elements are promising candidates for therapeutics. We aim to identify and develop strategy for correction of disease-associated aberrations using CRISPR and its derivative technology.
Curriculum Vitae
- 2026.03~Present: Associate Professor UNIST
- 2019~2026.02: Assistant Professor UNIST
- 2014~2018: Postdoctoral Research Associate, Howard Hughes Medical InstituteCenter for Personal Dynamic Regulomes, Stanford School of Medicine
Academic Credential
- 2014: Ph.D, Biochemistry, Seoul National University
- 2007; B.S. Chemistry, Chung-Ang University
Awards/Honors/Memberships
- 2021~2024: Highly Cited Researcher
- 2019~Present: Committee Member of Korean Aoociation for Genome Editing
- 2018: Patent and Technology Awards(Korean Intellectual Property Office)